A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants

• LUCAS K. G.

収録刊行物

• Hum Gene Ther.

  Hum Gene Ther. 11 1453-1463, 2000

詳細情報

• CRID: 1572261550478387840
• NII論文ID: 10021242645
• データソース種別:
  • CiNii Articles